Complete ICD-10-CM coding and documentation guide for Plasma Cell Tumor. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Complete code families applicable to Plasma Cell Tumor
Multiple myeloma and malignant plasma cell neoplasms
This range includes codes for various types of plasma cell tumors, including multiple myeloma, solitary plasmacytoma of bone, and extramedullary plasmacytoma.
Compare key differences between these codes to ensure accurate selection
Code | Description | When to Use | Key Documentation |
---|---|---|---|
C90.00 | Multiple myeloma not having achieved remission | Use when multiple myeloma is active and not in remission. |
|
C90.2 | Extramedullary plasmacytoma | Use for extramedullary plasmacytoma without systemic myeloma. |
|
C90.3 | Solitary plasmacytoma of bone | Use for solitary plasmacytoma of bone without systemic involvement. |
|
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Essential facts and insights about Plasma Cell Tumor
Use for extramedullary plasmacytoma without systemic myeloma.
Document absence of systemic involvement.
Use for solitary plasmacytoma of bone without systemic involvement.
Document solitary nature and absence of systemic involvement.
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Pathological fracture in neoplastic disease
M84.5Avoid these common documentation and coding issues when documenting Plasma Cell Tumor to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C90.00.
Clinical: Affects treatment planning and monitoring., Regulatory: Non-compliance with coding standards., Financial: Potential for incorrect reimbursement.
Always append the 7th character for remission status.
Reimbursement: Incorrect coding may lead to reduced reimbursement., Compliance: May result in non-compliance with coding guidelines., Data Quality: Affects accuracy of patient records.
Use C90.2 or C90.3 unless myeloma criteria are met.
Failure to document remission status accurately can lead to audit flags.
Implement regular training on remission coding and documentation.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Common questions about ICD-10 coding for Plasma Cell Tumor, with expert answers to help guide accurate code selection and documentation.
Use these documentation templates to ensure complete and accurate documentation for Plasma Cell Tumor. These templates include all required elements for proper coding and billing.
Need help with ICD-10 coding for Plasma Cell Tumor? Ask your questions below.